Document is current
Any future updates will be listed below
-
Authors
Geyer, Julie https://orcid.org/0000-0002-9579-379X
Opoku, Kofi B.
Lin, John
Ramkissoon, Lori
Mullighan, Charles https://orcid.org/0000-0002-1871-1850
Bhakta, Nickhill https://orcid.org/0000-0001-5282-7833
Alexander, Thomas B. https://orcid.org/0000-0002-0484-1574
Wang, Jeremy R. https://orcid.org/0000-0002-0673-9418
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA293366)
UNC | UNC-Chapel Hill | Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
- License Information
-
More Information
Article History
Received: 10 October 2024
Revised: 18 February 2025
Accepted: 11 March 2025
First Online: 24 March 2025
Competing interests
: JG and JRW have received compensation for travel to speak at Oxford Nanopore Technologies events. The remaining authors declare no competing interests.
: All methods were performed in accordance with the relevant guidelines and regulations. Patient specimens were obtained from the University of North Carolina at Chapel Hill (UNC) and St. Jude Children’s Research Hospital (SJCRH) “TBANK” Biorepository with approval by the University of North Carolina at Chapel Hill’s Biomedical Institutional Review Board approvals 17-2609 (Pediatric tumor biobank) and 19-0413 (Novel sequencing-based diagnostics). Informed consent was obtained from all participants.
